Forging a position as an innovative player in
infectious disease vaccines and therapies
Load more...

BioDiem- OPAL Update and EOFY Information

July 10, 2017

BioDiem_OPAL Update and EOFY information

Read More

Receipt of 2016 Income Tax Return Refund

May 22, 2017

20170522 Receipt of 2016 Income Tax Return Refund (BioDiem)

Read More

BioDiem Releases Half Year Results

March 17, 2017

BioDiem Releases Half Year Results

Read More

2016 Chairman’s Address

October 19, 2016

2016 Chairman’s Address

Read More

2016 BioDiem Results of Meeting

October 19, 2016

2016 BioDiem Results of Meeting

Read More

Opal Biosciences Annual Report and Notice of Meeting 2016 now available

October 4, 2016

Opal Biosciences Annual Report 2016 Opal Biosciences Notice of Meeting and proxy form 2016 For more information, visit www.opalbiosciences.com

Read More

BioDiem Notice of Annual General Meeting and Proxy form 2016

September 19, 2016

BioDiem Notice of Annual General Meeting and Proxy form 2016

Read More

BioDiem Annual Report 2016

September 19, 2016

BioDiem Annual Report 2016

Read More

Completion of Entitlement Offer and Issue of Convertible Preference Shares

August 10, 2016

Completion of Entitlement Offer and Issue of Convertible Preference Shares

Read More

Non-renounceable pro rata Entitlement Offer

June 14, 2016

Non-renounceable pro rata Entitlement Offer

Read More

BioDiem Entitlement Offer Replacement Prospectus

June 14, 2016

ENTITLEMENT OFFER REPLACEMENT PROSPECTUS   By accessing the BioDiem Limited Entitlement Offer Prospectus contained on this website (a copy of which has been lodged with ASIC), you must acknowledge the following terms and agree to be bound by them: A copy of this Prospectus was lodged with ASIC on 6 June 2016. Neither ASIC nor […]

Read More

Results of General Meeting

May 11, 2016

Results of General Meeting

Read More

BDM-I Presentation at European Clinical Conference

April 13, 2016

BDM-I Presentation at European Clinical Conference

Read More

Notice of General Meeting with Proxy

April 8, 2016

Notice of General Meeting with Proxy

Read More

Influenza Vaccine Clinical Trial commences in China

March 31, 2016

Influenza Vaccine Clinical Trial commences in China

Read More

BioDiem Releases Half Year Results

March 31, 2016

BioDiem Releases Half Year Results

Read More

BioDiem/Opal Biosciences Investor presentation at Wholesale Investor

February 26, 2016

BioDiem/Opal Biosciences Investor presentation at Wholesale Investor

Read More

Share Trading Contact Information

January 22, 2016

Share Trading Contact Information

Read More

Completion of Non-renounceable Entitlement Offer and Issue of Entitlement and Shortfall Shares

January 22, 2016

Completion of Non-renounceable Entitlement Offer and Issue of Entitlement and Shortfall Shares

Read More

Appointment of Prof Li to the BioDiem Board

January 22, 2016

Appointment of Prof Li to the BioDiem board

Read More

Receipt of 2015 Income Tax Return Refund

December 23, 2015

Receipt of 2015 Income Tax Return Refund (BioDiem) – (FINAL)

Read More

Rights Issue Closure and Results

December 22, 2015

Rights Issue Closure and Results Announcement – (FINAL)

Read More

Further US patent granted for Opal

December 11, 2015

Further US patent granted for Opal

Read More

BioDiem is presented at Wholesale Investor, Sydney

December 4, 2015

BioDiem is presented at Wholesale Investor, Sydney

Read More

BioDiem Rights Issue

November 27, 2015

BioDiem Rights Issue  and BioDiem Entitlement Offer Prospectus

Read More

BioDiem is presented at Wholesale Investor, Melbourne

November 25, 2015

BioDiem is presented at Wholesale Investor, Melbourne

Read More

BioDiem Entitlement Offer Prospectus

November 18, 2015

ENTITLEMENT OFFER PROSPECTUS By accessing the BioDiem Limited Entitlement Offer Prospectus contained on this website (a copy of which has been lodged with ASIC), you must acknowledge the following terms and agree to be bound by them: A copy of this Prospectus was lodged with ASIC on 17 November 2015. Neither ASIC nor its officers […]

Read More

New European patents for Opal Biosciences antimicrobial, BDM-I

November 6, 2015

New European patents for Opal Biosciences antimicrobial, BDM-I

Read More

Nasovac-S WHO PreQualification certification

October 21, 2015

NasovacS WHO PreQualification certification

Read More

AGM 2015 Presentation

October 20, 2015

AGM 2015 Presentation FINAL

Read More

2015 AGM CEO Address

October 20, 2015

CEO Address AGM 2015

Read More

Chairman’s Address AGM 2015

October 19, 2015

Chairman’s address AGM 2015

Read More

2015 Results of Meeting

October 19, 2015

2015 Results of Meeting

Read More

Chinese FDA gives approval to start LAIV vaccine clinical trials

September 24, 2015

Chinese FDA gives approval to start LAIV vaccine clinical trials    

Read More

BioDiem Notice of Annual General Meeting and Proxy form 2015

September 17, 2015

BioDiem Notice of Annual General Meeting and Proxy form 2015

Read More

BioDiem 2015 Annual Report

September 17, 2015

BioDiem 2015 Annual report

Read More

Opal Update

August 26, 2015

Opal Update

Read More

Shareholder Update

August 7, 2015

Shareholder Update

Read More

July 20, 2015

Opal Biosciences CEO Interview, Wholesale Investor

Read More

Opal’s technology presented at the Australian Society for Microbiology Annual Meeting

July 16, 2015

Opal’s technology presented at the Australian Society for Microbiology Annual Meeting

Read More

Opal Biosciences article in The Australian newspaper 13th July 2015

July 13, 2015

Opal Biosciences article in The Australian newspaper 13th July 2015

Read More

Successful grant for BDM-I – Griffith University

July 10, 2015

Successful grant for BDM-I – Griffith University

Read More

Opal Biosciences Investor Briefing, Melbourne 14 July 2015

July 7, 2015

Opal Biosciences Investor Briefing, Melbourne 14 July 2015

Read More

Opal Biosciences Investor Briefing, Sydney 13 July 2015

July 7, 2015

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Read More

Results of General Meeting

July 7, 2015

Results of General Meeting

Read More

Opal Biosciences’ anti-infective technology profiled at 2015 BIO International Convention

June 17, 2015

Opal Biociences’ anti-infective technology profiled at 2015 Bio International Convention

Read More

BioDiem Shareholder Update: Opal Biosciences Ltd.

June 5, 2015

Shareholder Update; Opal Biosciences

Read More

May 2015 Shareholder Update

May 14, 2015

May 2015 Shareholder Update

Read More

Board Announcement – Don Brooks

March 24, 2015

Board Announcement – Don Brooks

Read More

BioDiem Half Year Financial report

March 16, 2015

BioDiem Half Year Financial report

Read More

Notification of Exercise of Options

February 23, 2015

Notification of Exercise of Options

Read More

Notice of extension of exercise period for BioDiem options to 13th February 2015

January 6, 2015

Notice of extension of exercise period for BioDiem options to 13th February 2015

Read More

Extension of BDM option exercise closing date

December 30, 2014

Extension of BDM option exercise closing date

Read More

New Japanese patent for antimicrobial BDM-I

December 24, 2014

New Japanese patent for antimicrobial BDM-I

Read More

Professor Arthur Li directorship

December 24, 2014

Professor Arthur Li directorship

Read More

Wholesale Investor’s Sydney Capital Showcase and Australia Biotech Invest, Melbourne

December 5, 2014

Wholesale Investor’s Sydney Capital Showcase and Australia Biotech Invest, Melbourne.

Read More

BioDiem CEO appointed Chairman of Ausbiotech

December 5, 2014

BioDiem CEO appointed Chairman of Ausbiotech  

Read More